|
MechanismEPO receptor agonists [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Elanex Pharmaceuticals, Inc
0 Patents (Medical) associated with Elanex Pharmaceuticals, Inc
100 Deals associated with Elanex Pharmaceuticals, Inc
100 Translational Medicine associated with Elanex Pharmaceuticals, Inc